News | Page 93 | Englander Institute for Precision Medicine

Immunotherapy for Lung Cancer

December 28, 2020

Immunotherapy drugs, also known as immune checkpoint inhibitors, target cancer cells by recruiting and activating the body’s own immune cells to kill cancer cells. This approach—used for about seven years—has dramatically changed the treatment of patients with advanced lung cancer. The hope is to use immunotherapy on patients who are at even earlier stages of the...

Dr. Lisa Newman Receives Breast Cancer Research Grant

December 22, 2020

A recent grant from Susan G. Komen Greater NYC has funded the Breast Health Equity and International Breast Cancer Research Program at Weill Cornell Medicine. The generous $100,000 Catalyst Research Grant will support the program in addressing breast-cancer disparities through a multi-pronged approach. The program is led by Englander Institute for Precision Medicine...

COVID Summit: Social Science Perspectives

December 21, 2020

The social sciences are essential to understanding how COVID-19 has spread and its impacts on individuals and society.

How should models of pandemic illnesses be constructed? What are the racial disparities in clinical outcomes for patients with COVID-19? How are emergency room physicians coping with the stress of an overwhelmed hospital system? These are just some of the questions explored by panelists who took part in a session on social sciences and...